Rafael Holdings, Inc. - מכפיל P/S עתידי RFL

Growth prospects are driven by biotech assets, while real estate rentals generate current cash flow for Rafael Holdings, Inc. (RFL). The forward P/S ratio confirms this trend, with 56.60 characterizing this valuation parameter. Moderate crisis resilience is ensured by portfolio diversification. Yield flexibility is based on the ownership of medical patents and unique real estate properties.
פילוחי מדדים מקיפים ואנליטיקה עבור Rafael Holdings, Inc. (RFL)

Forward P/S measures the market value of a business relative to its projected annual revenue, allowing for an assessment of the premium investors are willing to pay for every dollar of expected sales. For Rafael Holdings, Inc. (RFL), with its capital-intensive assets in biopharmaceuticals and real estate, the forward P/S valuation serves as an indicator of capitalization resilience against regulatory risks and debt service costs.